Susan Hasty, Publisher
Table of Contents . . . September 29th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Vaccine Week | Other Publications
RNA Research - N- and C-terminal zinc fingers in HIV NC protein have different roles
RNA Research - The HIV group O frameshift stimulatory signal is a pseudoknot
HIV/AIDS Pathogenesis - Intestinal cell cycle dysregulation occurs during SIV infection
Therapeutic Vaccines - Update provided on HIV, cancer vaccines, workforce reduction
AIDS Prevention - Bacteria may show promise in AIDS fight
Finance - Dawson James Securities initiates coverage of HIV vaccine developer
HIV Therapy - Phase I trial of autologous VRX496 modified T cells deemed safe
HIV/AIDS Dyslipidemia - Mechanisms underlying hypertriglyceridemia in HIV patients elucidated
HIV/AIDS Neurotoxicity - HIV infection impairs astrocyte glutamate transport
HIV/AIDS Pathogenesis - Vav prevents HIV Nef-induced GM1 downregulation and NF-AT inhibition
HIV/AIDS RNA Research - Tat acetylation needed for CyclinT1-independent HIV transactivation
HIV/AIDS Therapy - Baseline immune markers do not predict discordant antiretroviral treatment responses
HIV/AIDS Therapy - Didanosine remains active against HIV strains with M184V/I mutation
HIV/AIDS Therapy - Drug levels in untimed plasma samples predict treatment outcome in advanced HIV patients
HIV/AIDS Therapy - Lipid-lowering drug use rising in PI-treated HIV patients
HIV/AIDS Therapy - Lopinavir-ritonavir regimens reduce methadone efficacy
Immunology - CD44 mediates CCL5-induced cell activation and HIV infectivity enhancement
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.